Session 5 – A New Paradigm in Biotech Innovation & Investment
Date: 22 July (Wednesday) 15:40 – 17:10 (GMT+8)
Venue: 701EF, 7F, TaiNEX2 / Online event platform
Jerome Shen, Ph.D., is General Partner of Life Science Investments of Taiwania Capital Management Corporation.
Prior to joining Taiwania, he was the President and co-founder of Allgenesis Biotherapeutics Inc., a new drug development company addressing the unmet medical needs in the ophthalmology areas since 2014. Prior to Allgenesis, he was the executive of the venture capital firms in Cheng Xin Ventures and Xinchen Ventures for 20 years, focusing on investment in the life science and biotech/pharmaceutical industry. He has extensive working experiences with bio-scientific entrepreneurs in the startup businesses to help them grow the corporate value.
In addition to the venture capital businesses, he also took the executive positions in the biotech start-ups, responsible for corporate development and strategic initiatives and planning. Dr. Shen was the Secretary General of Taiwan Biotech Association, a non-profit organization, from 2005 to 2008. The mission of Taiwan Biotech Association was to provide services to the industry members in business development, human resources, and training programs.
He received his Ph.D. in Chemical Engineering from the University of Wisconsin, Madison.